Medical technology company Peptonic Medical is approaching the first delivery within its partner agreement with a US player in intimate self-care for women. The agreement covers the US, Canada, Mexico and the UK, where the products are sold under the partner's own brand.The first order, worth about SEK 1 million, was received in October last year. According to the company, work on product design and delivery preparations is proceeding according to the set plan. - That we are now approaching the first delivery within the agreement is an important milestone for Peptonic. It shows both the international relevance of our product portfolio and our ability to build scalable growth through partnerships. The US and the other agreed markets are strategically important to us, and this is a concrete step in our ambition to reach more women with effective, gentle and science-based products within intimate self-care, says Daniel Rudeklint, interim CEO of Peptonic Medical.